SCHEMBL6330723

SCHEMBL6330723

COC(=O)c1cccc(C(O)CN)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.58
SLC7A5 Q01650 1/20 0.50
CYP4F2 P78329 2/20 0.49
CYP4A11 Q02928 2/20 0.49
ALDH1A1 P00352 1/20 0.47
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
PNMT P11086 1/20 0.46
CASR P41180 1/20 0.46
TSHR P16473 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NFKB1 P19838 1/20 0.45
PARP1 P09874 1/20 0.45
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5662355 0.86 LOXL2 (0.51) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL9359858 0.86 CYP4F2 (0.54) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL4446181 0.84 LOXL2 (0.62) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL15671512 0.84 LOXL2 (0.58) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL3182845 0.83 CYP4F2 (0.55) LOXL2SLC7A5CYP4F2CYP4A11ADRB2
SCHEMBL22076564 0.83 F2 (0.51) LOXL2SLC7A5CYP4F2CYP4A11ADRB2
SCHEMBL23746337 0.82 LOXL2 (0.48) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL23732388 0.82 LOXL2 (0.48) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL23746338 0.82 LOXL2 (0.48) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1
SCHEMBL31226811 0.82 LOXL2 (0.48) LOXL2SLC7A5CYP4F2CYP4A11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116829532-A Substituted cyclohexane carboxamides, their preparation and their therapeutic use 赛诺菲 2023-09-29 CN disclosed
US-6878734-B2 Gastrin and cholecystokinin receptor ligands(II) JAMES BLACK FOUNDATION LIMITED (GB) 2005-04-12 US disclosed
US-20030199565-A1 Gastrin and cholecystokinin receptor ligands(II) JAMES BLACK FOUNDATION LIMITED (GB) 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199565-A1 Gastrin and cholecystokinin receptor ligands(II) GRPR, CCKBR, GIPR LOXL2 3530/4885SLC7A5 1259/4885CYP4F2 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.